 iHerb | $ 21.45 |
Branded MK-7, MK-4, and vitamin K1 create unusually broad vitamin K coverage with all major amounts disclosed. The label provides enough detail to judge the central vitamin strategy.
The total vitamin K exposure is very high and dry-tablet delivery lacks a fat carrier, making the formula more specialized than routine. Format, dose, and companion nutrients determine whether it is appropriate for daily use.
The best fit is adults using a professionally directed multi-form vitamin K plan. Vitamin K and vitamin D support normal physiology, but the practical benefit depends on baseline intake and individual need.
Branded MenaQ7 is a well-characterized MK-7 form, while MK-4 and K1 are also identified, and menaQ7 is present at a meaningful 180 mcg, with substantial additional K1 and MK-4. The very high total vitamin K amount is more aggressive than most general-use formulas, while k1, MK-4, and MK-7 provide broad vitamin K coverage, while the small calcium addition has limited impact.
.Every listed active ingredient has a specific amount, and no proprietary blend hides the dose of a listed active ingredient. Serving count is supplied, but complete daily-use directions are not provided, while inactive ingredients and excipients are not included in the supplied label details.
.The supplied average rating is strong, and the relatively limited review count reduces confidence in the average rating. Specific review themes are unavailable, so repeated negatives and real-world fit remain uncertain.
.The ingredient forms and dosing generally justify the product positioning, and the moderate serving cost is reasonable for the disclosed actives. The small calcium addition has limited value but does not dominate the formula, while the formula and serving value compare well with similar products.
.
Branded MenaQ7 supplies 180 mcg of MK-7 alongside 200 mcg of MK-4 and vitamin K1. The clearly disclosed forms provide strong depth for vitamin K-dependent calcium regulation.
The formula does not address lipids, nitric oxide, or cardiac energy, and the dry tablet lacks a stated fat carrier. The high total vitamin K amount can oppose warfarin-type anticoagulants and requires prescriber guidance for users of those medicines.
MK-7 and MK-4 support activation of proteins that help bind calcium into bone, while vitamin K1 adds another established vitamin K form. The branded MK-7 amount is strong and clearly disclosed.
The dry tablet lacks a lipid carrier, and the small calcium amount does not provide meaningful structural mineral support. The high total vitamin K content requires special care with warfarin and similar vitamin K antagonist medicines because it can counter their effect.
Branded MK-7, MK-4, and K1 provide a substantial vitamin K profile for bone proteins and control of calcium placement in tissues. The 180 mcg MK-7 amount is well aligned with targeted cardiovascular and skeletal support.
The dry tablet lacks a stated fat-based carrier, which may limit absorption of these fat-soluble forms. The high total vitamin K content can counteract warfarin and similar vitamin K antagonists, so users of those medicines need consistent intake managed by their clinician.
Multiple vitamin K forms provide focused support for calcium handling, bone health, and vascular function. A useful MK-7 amount and a named branded source strengthen confidence in the formula.
The dry tablet lacks a fat-based delivery system, so taking it with food containing fat may improve practical absorption. The high vitamin K content is unsuitable for unsupervised use with warfarin or similar vitamin K antagonist medicines.
MK-7 and MK-4 support calcium-regulating proteins and may help maintain arterial flexibility. The large K1 component is less targeted, while direct cardiovascular outcome evidence remains less conclusive.
The K2 amounts are meaningful and clearly separated, although the dry tablet lacks stated fat-based delivery. The high total vitamin K content can strongly interfere with warfarin and similar vitamin K antagonists.
| Ingredient | Amount per serving |
|---|---|
Vitamin K1 (Phytonadione) | 1820 mcg |
Vitamin K2 (Menaquinone-4) | 200 mcg |
Vitamin K2 (Mena Q7) | 180 mcg |
Calcium (Dibasic Calcium Phosphate) | 63 mg |
Branded MenaQ7 supplies a well-aligned 180 mcg MK-7 dose, supported by clearly disclosed MK-4 and K1 amounts. The dry tablet lacks stated fat-based delivery or meal guidance, which may limit absorption compared with an oil-based format. Its low serving cost supports strong value, although the high total vitamin K content warrants particular care for people using warfarin or similar vitamin K antagonist medicines.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
